nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminoglutethimide—CYP11A1—Cholecalciferol—psoriasis	0.253	0.293	CbGbCtD
Aminoglutethimide—CYP11A1—Dexamethasone—psoriasis	0.109	0.127	CbGbCtD
Aminoglutethimide—CYP19A1—Betamethasone—psoriasis	0.0876	0.101	CbGbCtD
Aminoglutethimide—CYP1A2—Clobetasol propionate—psoriasis	0.0819	0.0948	CbGbCtD
Aminoglutethimide—CYP19A1—Dexamethasone—psoriasis	0.051	0.059	CbGbCtD
Aminoglutethimide—CYP1A2—Methoxsalen—psoriasis	0.043	0.0498	CbGbCtD
Aminoglutethimide—CYP2C19—Cholecalciferol—psoriasis	0.0309	0.0358	CbGbCtD
Aminoglutethimide—CYP3A4—Calcitriol—psoriasis	0.029	0.0335	CbGbCtD
Aminoglutethimide—CYP3A4—Methoxsalen—psoriasis	0.0225	0.0261	CbGbCtD
Aminoglutethimide—CYP2C19—Prednisone—psoriasis	0.0214	0.0248	CbGbCtD
Aminoglutethimide—CYP2C19—Cyclosporine—psoriasis	0.0203	0.0235	CbGbCtD
Aminoglutethimide—CYP3A4—Cholecalciferol—psoriasis	0.0149	0.0173	CbGbCtD
Aminoglutethimide—CYP2C19—Dexamethasone—psoriasis	0.0134	0.0155	CbGbCtD
Aminoglutethimide—CYP3A4—Mycophenolate mofetil—psoriasis	0.0129	0.015	CbGbCtD
Aminoglutethimide—CYP3A4—Triamcinolone—psoriasis	0.0129	0.015	CbGbCtD
Aminoglutethimide—CYP3A4—Betamethasone—psoriasis	0.0111	0.0129	CbGbCtD
Aminoglutethimide—CYP3A4—Prednisolone—psoriasis	0.011	0.0127	CbGbCtD
Aminoglutethimide—CYP3A4—Hydrocortisone—psoriasis	0.0104	0.012	CbGbCtD
Aminoglutethimide—CYP3A4—Prednisone—psoriasis	0.0103	0.012	CbGbCtD
Aminoglutethimide—CYP3A4—Cyclosporine—psoriasis	0.00981	0.0114	CbGbCtD
Aminoglutethimide—CYP3A4—Dexamethasone—psoriasis	0.00646	0.00748	CbGbCtD
Aminoglutethimide—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.000969	0.0747	CbGpPWpGaD
Aminoglutethimide—Dermatitis—Tazarotene—psoriasis	0.000822	0.00666	CcSEcCtD
Aminoglutethimide—Pancytopenia—Hydroxyurea—psoriasis	0.000819	0.00663	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Clobetasol propionate—psoriasis	0.000815	0.0066	CcSEcCtD
Aminoglutethimide—Neutropenia—Hydroxyurea—psoriasis	0.000807	0.00653	CcSEcCtD
Aminoglutethimide—Urticaria—Beclomethasone—psoriasis	0.0008	0.00648	CcSEcCtD
Aminoglutethimide—Pruritus—Clobetasol propionate—psoriasis	0.000783	0.00634	CcSEcCtD
Aminoglutethimide—CYP11A1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000776	0.0598	CbGpPWpGaD
Aminoglutethimide—Drowsiness—Hydroxyurea—psoriasis	0.000769	0.00623	CcSEcCtD
Aminoglutethimide—CYP11A1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000765	0.059	CbGpPWpGaD
Aminoglutethimide—Hypotension—Methoxsalen—psoriasis	0.000736	0.00596	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Fluocinonide—psoriasis	0.000735	0.00596	CcSEcCtD
Aminoglutethimide—Myalgia—Calcitriol—psoriasis	0.000733	0.00593	CcSEcCtD
Aminoglutethimide—Haemolytic anaemia—Mycophenolate mofetil—psoriasis	0.000731	0.00592	CcSEcCtD
Aminoglutethimide—Pruritus—Fluocinonide—psoriasis	0.000706	0.00572	CcSEcCtD
Aminoglutethimide—Rash—Clobetasol propionate—psoriasis	0.000698	0.00565	CcSEcCtD
Aminoglutethimide—Dermatitis—Clobetasol propionate—psoriasis	0.000697	0.00565	CcSEcCtD
Aminoglutethimide—Headache—Clobetasol propionate—psoriasis	0.000693	0.00562	CcSEcCtD
Aminoglutethimide—Pancytopenia—Mycophenolic acid—psoriasis	0.000686	0.00556	CcSEcCtD
Aminoglutethimide—Neutropenia—Mycophenolic acid—psoriasis	0.000675	0.00547	CcSEcCtD
Aminoglutethimide—Anorexia—Calcitriol—psoriasis	0.000669	0.00542	CcSEcCtD
Aminoglutethimide—Hepatotoxicity—Methotrexate—psoriasis	0.000667	0.0054	CcSEcCtD
Aminoglutethimide—Dizziness—Beclomethasone—psoriasis	0.000666	0.0054	CcSEcCtD
Aminoglutethimide—Dizziness—Fluocinonide—psoriasis	0.00066	0.00535	CcSEcCtD
Aminoglutethimide—Myalgia—Acitretin—psoriasis	0.000652	0.00528	CcSEcCtD
Aminoglutethimide—CYP11A1—Corticotropin-releasing hormone—IVL—psoriasis	0.000648	0.05	CbGpPWpGaD
Aminoglutethimide—Musculoskeletal discomfort—Calcitriol—psoriasis	0.00064	0.00518	CcSEcCtD
Aminoglutethimide—Rash—Beclomethasone—psoriasis	0.000635	0.00514	CcSEcCtD
Aminoglutethimide—Dermatitis—Beclomethasone—psoriasis	0.000635	0.00514	CcSEcCtD
Aminoglutethimide—Headache—Beclomethasone—psoriasis	0.000631	0.00511	CcSEcCtD
Aminoglutethimide—Rash—Fluocinonide—psoriasis	0.000629	0.0051	CcSEcCtD
Aminoglutethimide—Dermatitis—Fluocinonide—psoriasis	0.000629	0.00509	CcSEcCtD
Aminoglutethimide—CYP11A1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000629	0.0485	CbGpPWpGaD
Aminoglutethimide—Urticaria—Methoxsalen—psoriasis	0.000626	0.00507	CcSEcCtD
Aminoglutethimide—Headache—Fluocinonide—psoriasis	0.000625	0.00506	CcSEcCtD
Aminoglutethimide—Somnolence—Calcitriol—psoriasis	0.000624	0.00506	CcSEcCtD
Aminoglutethimide—Body temperature increased—Methoxsalen—psoriasis	0.000623	0.00504	CcSEcCtD
Aminoglutethimide—Decreased appetite—Calcitriol—psoriasis	0.00061	0.00494	CcSEcCtD
Aminoglutethimide—Agranulocytosis—Mycophenolic acid—psoriasis	0.000601	0.00487	CcSEcCtD
Aminoglutethimide—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.0006	0.0463	CbGpPWpGaD
Aminoglutethimide—Nausea—Beclomethasone—psoriasis	0.000598	0.00485	CcSEcCtD
Aminoglutethimide—Anorexia—Acitretin—psoriasis	0.000596	0.00482	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Methoxsalen—psoriasis	0.00058	0.0047	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Acitretin—psoriasis	0.000569	0.00461	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Fluocinolone Acetonide—psoriasis	0.000568	0.0046	CcSEcCtD
Aminoglutethimide—Urticaria—Calcitriol—psoriasis	0.000558	0.00452	CcSEcCtD
Aminoglutethimide—Pruritus—Methoxsalen—psoriasis	0.000557	0.00451	CcSEcCtD
Aminoglutethimide—Anaemia—Hydroxyurea—psoriasis	0.000555	0.0045	CcSEcCtD
Aminoglutethimide—Somnolence—Acitretin—psoriasis	0.000555	0.0045	CcSEcCtD
Aminoglutethimide—Body temperature increased—Calcitriol—psoriasis	0.000555	0.0045	CcSEcCtD
Aminoglutethimide—Decreased appetite—Acitretin—psoriasis	0.000543	0.0044	CcSEcCtD
Aminoglutethimide—Pancytopenia—Mycophenolate mofetil—psoriasis	0.000541	0.00439	CcSEcCtD
Aminoglutethimide—Leukopenia—Hydroxyurea—psoriasis	0.000538	0.00436	CcSEcCtD
Aminoglutethimide—Neutropenia—Mycophenolate mofetil—psoriasis	0.000533	0.00432	CcSEcCtD
Aminoglutethimide—Dizziness—Methoxsalen—psoriasis	0.000521	0.00422	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Calcitriol—psoriasis	0.000517	0.00419	CcSEcCtD
Aminoglutethimide—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000514	0.0396	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000507	0.0391	CbGpPWpGaD
Aminoglutethimide—Pruritus—Calcitriol—psoriasis	0.000497	0.00402	CcSEcCtD
Aminoglutethimide—Rash—Methoxsalen—psoriasis	0.000497	0.00402	CcSEcCtD
Aminoglutethimide—Dermatitis—Methoxsalen—psoriasis	0.000496	0.00402	CcSEcCtD
Aminoglutethimide—Urticaria—Acitretin—psoriasis	0.000496	0.00402	CcSEcCtD
Aminoglutethimide—Body temperature increased—Acitretin—psoriasis	0.000494	0.004	CcSEcCtD
Aminoglutethimide—Headache—Methoxsalen—psoriasis	0.000494	0.004	CcSEcCtD
Aminoglutethimide—Body temperature increased—Fluocinolone Acetonide—psoriasis	0.000492	0.00399	CcSEcCtD
Aminoglutethimide—Agranulocytosis—Mycophenolate mofetil—psoriasis	0.000474	0.00384	CcSEcCtD
Aminoglutethimide—Nausea—Methoxsalen—psoriasis	0.000468	0.00379	CcSEcCtD
Aminoglutethimide—CYP1A2—Xenobiotics—CYP2S1—psoriasis	0.000468	0.0361	CbGpPWpGaD
Aminoglutethimide—Anorexia—Hydroxyurea—psoriasis	0.000468	0.00379	CcSEcCtD
Aminoglutethimide—Anaemia—Mycophenolic acid—psoriasis	0.000465	0.00377	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Acitretin—psoriasis	0.00046	0.00373	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Fluocinolone Acetonide—psoriasis	0.000459	0.00372	CcSEcCtD
Aminoglutethimide—Leukopenia—Mycophenolic acid—psoriasis	0.000451	0.00365	CcSEcCtD
Aminoglutethimide—Vomiting—Calcitriol—psoriasis	0.000446	0.00362	CcSEcCtD
Aminoglutethimide—Rash—Calcitriol—psoriasis	0.000443	0.00359	CcSEcCtD
Aminoglutethimide—Dermatitis—Calcitriol—psoriasis	0.000442	0.00358	CcSEcCtD
Aminoglutethimide—Pruritus—Acitretin—psoriasis	0.000442	0.00358	CcSEcCtD
Aminoglutethimide—Pruritus—Fluocinolone Acetonide—psoriasis	0.000441	0.00357	CcSEcCtD
Aminoglutethimide—Headache—Calcitriol—psoriasis	0.00044	0.00356	CcSEcCtD
Aminoglutethimide—Somnolence—Hydroxyurea—psoriasis	0.000436	0.00353	CcSEcCtD
Aminoglutethimide—Myalgia—Mycophenolic acid—psoriasis	0.000429	0.00347	CcSEcCtD
Aminoglutethimide—Decreased appetite—Hydroxyurea—psoriasis	0.000426	0.00345	CcSEcCtD
Aminoglutethimide—Nausea—Calcitriol—psoriasis	0.000417	0.00338	CcSEcCtD
Aminoglutethimide—CYP19A1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000416	0.0321	CbGpPWpGaD
Aminoglutethimide—Dizziness—Acitretin—psoriasis	0.000413	0.00335	CcSEcCtD
Aminoglutethimide—Dizziness—Fluocinolone Acetonide—psoriasis	0.000412	0.00334	CcSEcCtD
Aminoglutethimide—Tachycardia—Mycophenolic acid—psoriasis	0.000401	0.00325	CcSEcCtD
Aminoglutethimide—Vomiting—Acitretin—psoriasis	0.000397	0.00322	CcSEcCtD
Aminoglutethimide—Vomiting—Fluocinolone Acetonide—psoriasis	0.000396	0.00321	CcSEcCtD
Aminoglutethimide—Rash—Acitretin—psoriasis	0.000394	0.00319	CcSEcCtD
Aminoglutethimide—Dermatitis—Acitretin—psoriasis	0.000394	0.00319	CcSEcCtD
Aminoglutethimide—Rash—Fluocinolone Acetonide—psoriasis	0.000393	0.00318	CcSEcCtD
Aminoglutethimide—Dermatitis—Fluocinolone Acetonide—psoriasis	0.000392	0.00318	CcSEcCtD
Aminoglutethimide—Anorexia—Mycophenolic acid—psoriasis	0.000392	0.00317	CcSEcCtD
Aminoglutethimide—Headache—Acitretin—psoriasis	0.000391	0.00317	CcSEcCtD
Aminoglutethimide—Headache—Fluocinolone Acetonide—psoriasis	0.00039	0.00316	CcSEcCtD
Aminoglutethimide—Body temperature increased—Hydroxyurea—psoriasis	0.000388	0.00314	CcSEcCtD
Aminoglutethimide—Hypotension—Mycophenolic acid—psoriasis	0.000384	0.00311	CcSEcCtD
Aminoglutethimide—Anaemia—Cyclosporine—psoriasis	0.000376	0.00305	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Mycophenolic acid—psoriasis	0.000374	0.00303	CcSEcCtD
Aminoglutethimide—Nausea—Acitretin—psoriasis	0.000371	0.00301	CcSEcCtD
Aminoglutethimide—Nausea—Fluocinolone Acetonide—psoriasis	0.00037	0.003	CcSEcCtD
Aminoglutethimide—Anaemia—Mycophenolate mofetil—psoriasis	0.000367	0.00297	CcSEcCtD
Aminoglutethimide—Somnolence—Mycophenolic acid—psoriasis	0.000365	0.00296	CcSEcCtD
Aminoglutethimide—Leukopenia—Cyclosporine—psoriasis	0.000364	0.00295	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Hydroxyurea—psoriasis	0.000361	0.00293	CcSEcCtD
Aminoglutethimide—Neutropenia—Prednisone—psoriasis	0.000361	0.00293	CcSEcCtD
Aminoglutethimide—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000361	0.0279	CbGpPWpGaD
Aminoglutethimide—Decreased appetite—Mycophenolic acid—psoriasis	0.000357	0.00289	CcSEcCtD
Aminoglutethimide—Leukopenia—Mycophenolate mofetil—psoriasis	0.000356	0.00288	CcSEcCtD
Aminoglutethimide—Myalgia—Cyclosporine—psoriasis	0.000347	0.00281	CcSEcCtD
Aminoglutethimide—Myalgia—Mycophenolate mofetil—psoriasis	0.000338	0.00274	CcSEcCtD
Aminoglutethimide—CYP11A1—Biological oxidations—CYP2S1—psoriasis	0.000334	0.0258	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metapathway biotransformation—CYP2S1—psoriasis	0.000329	0.0254	CbGpPWpGaD
Aminoglutethimide—Body temperature increased—Mycophenolic acid—psoriasis	0.000325	0.00263	CcSEcCtD
Aminoglutethimide—Dizziness—Hydroxyurea—psoriasis	0.000324	0.00263	CcSEcCtD
Aminoglutethimide—Anorexia—Cyclosporine—psoriasis	0.000317	0.00257	CcSEcCtD
Aminoglutethimide—Tachycardia—Mycophenolate mofetil—psoriasis	0.000316	0.00256	CcSEcCtD
Aminoglutethimide—Vomiting—Hydroxyurea—psoriasis	0.000312	0.00253	CcSEcCtD
Aminoglutethimide—Rash—Hydroxyurea—psoriasis	0.000309	0.0025	CcSEcCtD
Aminoglutethimide—Anorexia—Mycophenolate mofetil—psoriasis	0.000309	0.0025	CcSEcCtD
Aminoglutethimide—Dermatitis—Hydroxyurea—psoriasis	0.000309	0.0025	CcSEcCtD
Aminoglutethimide—Myalgia—Hydrocortisone—psoriasis	0.000308	0.0025	CcSEcCtD
Aminoglutethimide—Headache—Hydroxyurea—psoriasis	0.000307	0.00249	CcSEcCtD
Aminoglutethimide—Pancytopenia—Methotrexate—psoriasis	0.000307	0.00248	CcSEcCtD
Aminoglutethimide—Hypotension—Mycophenolate mofetil—psoriasis	0.000303	0.00245	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000303	0.00245	CcSEcCtD
Aminoglutethimide—Neutropenia—Methotrexate—psoriasis	0.000302	0.00245	CcSEcCtD
Aminoglutethimide—Somnolence—Cyclosporine—psoriasis	0.000295	0.00239	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000295	0.00239	CcSEcCtD
Aminoglutethimide—Tachycardia—Prednisolone—psoriasis	0.000295	0.00239	CcSEcCtD
Aminoglutethimide—Nausea—Hydroxyurea—psoriasis	0.000291	0.00236	CcSEcCtD
Aminoglutethimide—Pruritus—Mycophenolic acid—psoriasis	0.000291	0.00235	CcSEcCtD
Aminoglutethimide—Myalgia—Triamcinolone—psoriasis	0.00029	0.00235	CcSEcCtD
Aminoglutethimide—Decreased appetite—Cyclosporine—psoriasis	0.000289	0.00234	CcSEcCtD
Aminoglutethimide—Tachycardia—Hydrocortisone—psoriasis	0.000288	0.00233	CcSEcCtD
Aminoglutethimide—Somnolence—Mycophenolate mofetil—psoriasis	0.000288	0.00233	CcSEcCtD
Aminoglutethimide—Drowsiness—Methotrexate—psoriasis	0.000288	0.00233	CcSEcCtD
Aminoglutethimide—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000282	0.00228	CcSEcCtD
Aminoglutethimide—Anorexia—Hydrocortisone—psoriasis	0.000282	0.00228	CcSEcCtD
Aminoglutethimide—Hypotension—Hydrocortisone—psoriasis	0.000276	0.00224	CcSEcCtD
Aminoglutethimide—Dizziness—Mycophenolic acid—psoriasis	0.000272	0.0022	CcSEcCtD
Aminoglutethimide—Tachycardia—Triamcinolone—psoriasis	0.000271	0.0022	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000269	0.00218	CcSEcCtD
Aminoglutethimide—Agranulocytosis—Methotrexate—psoriasis	0.000269	0.00218	CcSEcCtD
Aminoglutethimide—Urticaria—Cyclosporine—psoriasis	0.000264	0.00214	CcSEcCtD
Aminoglutethimide—Myalgia—Betamethasone—psoriasis	0.000263	0.00213	CcSEcCtD
Aminoglutethimide—Myalgia—Dexamethasone—psoriasis	0.000263	0.00213	CcSEcCtD
Aminoglutethimide—Body temperature increased—Cyclosporine—psoriasis	0.000263	0.00213	CcSEcCtD
Aminoglutethimide—Vomiting—Mycophenolic acid—psoriasis	0.000261	0.00212	CcSEcCtD
Aminoglutethimide—Rash—Mycophenolic acid—psoriasis	0.000259	0.0021	CcSEcCtD
Aminoglutethimide—Dermatitis—Mycophenolic acid—psoriasis	0.000259	0.0021	CcSEcCtD
Aminoglutethimide—Urticaria—Mycophenolate mofetil—psoriasis	0.000258	0.00209	CcSEcCtD
Aminoglutethimide—Headache—Mycophenolic acid—psoriasis	0.000257	0.00208	CcSEcCtD
Aminoglutethimide—Decreased appetite—Hydrocortisone—psoriasis	0.000257	0.00208	CcSEcCtD
Aminoglutethimide—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000256	0.00208	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000253	0.00205	CcSEcCtD
Aminoglutethimide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000249	0.0192	CbGpPWpGaD
Aminoglutethimide—Anaemia—Prednisone—psoriasis	0.000249	0.00202	CcSEcCtD
Aminoglutethimide—CYP19A1—Ovarian Infertility Genes—VDR—psoriasis	0.000248	0.0191	CbGpPWpGaD
Aminoglutethimide—Tachycardia—Dexamethasone—psoriasis	0.000246	0.00199	CcSEcCtD
Aminoglutethimide—Tachycardia—Betamethasone—psoriasis	0.000246	0.00199	CcSEcCtD
Aminoglutethimide—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000246	0.019	CbGpPWpGaD
Aminoglutethimide—Hypersensitivity—Cyclosporine—psoriasis	0.000245	0.00198	CcSEcCtD
Aminoglutethimide—Nausea—Mycophenolic acid—psoriasis	0.000244	0.00198	CcSEcCtD
Aminoglutethimide—Anorexia—Betamethasone—psoriasis	0.000241	0.00195	CcSEcCtD
Aminoglutethimide—Anorexia—Dexamethasone—psoriasis	0.000241	0.00195	CcSEcCtD
Aminoglutethimide—Urticaria—Prednisolone—psoriasis	0.00024	0.00195	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000239	0.00193	CcSEcCtD
Aminoglutethimide—Hypotension—Dexamethasone—psoriasis	0.000236	0.00191	CcSEcCtD
Aminoglutethimide—Hypotension—Betamethasone—psoriasis	0.000236	0.00191	CcSEcCtD
Aminoglutethimide—Pruritus—Cyclosporine—psoriasis	0.000235	0.0019	CcSEcCtD
Aminoglutethimide—Urticaria—Hydrocortisone—psoriasis	0.000235	0.0019	CcSEcCtD
Aminoglutethimide—Body temperature increased—Hydrocortisone—psoriasis	0.000233	0.00189	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.00023	0.00186	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Betamethasone—psoriasis	0.00023	0.00186	CcSEcCtD
Aminoglutethimide—Pruritus—Mycophenolate mofetil—psoriasis	0.000229	0.00186	CcSEcCtD
Aminoglutethimide—Myalgia—Prednisone—psoriasis	0.000229	0.00186	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Prednisolone—psoriasis	0.000223	0.0018	CcSEcCtD
Aminoglutethimide—CYP19A1—Biological oxidations—CYP2S1—psoriasis	0.000221	0.0171	CbGpPWpGaD
Aminoglutethimide—Urticaria—Triamcinolone—psoriasis	0.000221	0.00179	CcSEcCtD
Aminoglutethimide—Body temperature increased—Triamcinolone—psoriasis	0.00022	0.00178	CcSEcCtD
Aminoglutethimide—Dizziness—Cyclosporine—psoriasis	0.00022	0.00178	CcSEcCtD
Aminoglutethimide—Decreased appetite—Dexamethasone—psoriasis	0.000219	0.00178	CcSEcCtD
Aminoglutethimide—Decreased appetite—Betamethasone—psoriasis	0.000219	0.00178	CcSEcCtD
Aminoglutethimide—CYP19A1—Metapathway biotransformation—CYP2S1—psoriasis	0.000218	0.0168	CbGpPWpGaD
Aminoglutethimide—Hypersensitivity—Hydrocortisone—psoriasis	0.000218	0.00176	CcSEcCtD
Aminoglutethimide—Tachycardia—Prednisone—psoriasis	0.000214	0.00174	CcSEcCtD
Aminoglutethimide—Dizziness—Mycophenolate mofetil—psoriasis	0.000214	0.00174	CcSEcCtD
Aminoglutethimide—Vomiting—Cyclosporine—psoriasis	0.000211	0.00171	CcSEcCtD
Aminoglutethimide—Rash—Cyclosporine—psoriasis	0.00021	0.0017	CcSEcCtD
Aminoglutethimide—Anorexia—Prednisone—psoriasis	0.000209	0.0017	CcSEcCtD
Aminoglutethimide—Dermatitis—Cyclosporine—psoriasis	0.000209	0.0017	CcSEcCtD
Aminoglutethimide—Pruritus—Hydrocortisone—psoriasis	0.000209	0.00169	CcSEcCtD
Aminoglutethimide—Headache—Cyclosporine—psoriasis	0.000208	0.00169	CcSEcCtD
Aminoglutethimide—Anaemia—Methotrexate—psoriasis	0.000208	0.00168	CcSEcCtD
Aminoglutethimide—Vomiting—Mycophenolate mofetil—psoriasis	0.000206	0.00167	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Triamcinolone—psoriasis	0.000205	0.00166	CcSEcCtD
Aminoglutethimide—Rash—Mycophenolate mofetil—psoriasis	0.000204	0.00166	CcSEcCtD
Aminoglutethimide—Dermatitis—Mycophenolate mofetil—psoriasis	0.000204	0.00165	CcSEcCtD
Aminoglutethimide—Headache—Mycophenolate mofetil—psoriasis	0.000203	0.00164	CcSEcCtD
Aminoglutethimide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000202	0.0156	CbGpPWpGaD
Aminoglutethimide—Leukopenia—Methotrexate—psoriasis	0.000201	0.00163	CcSEcCtD
Aminoglutethimide—Urticaria—Betamethasone—psoriasis	0.0002	0.00162	CcSEcCtD
Aminoglutethimide—Urticaria—Dexamethasone—psoriasis	0.0002	0.00162	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Prednisone—psoriasis	0.0002	0.00162	CcSEcCtD
Aminoglutethimide—Dizziness—Prednisolone—psoriasis	0.0002	0.00162	CcSEcCtD
Aminoglutethimide—Body temperature increased—Betamethasone—psoriasis	0.000199	0.00162	CcSEcCtD
Aminoglutethimide—Body temperature increased—Dexamethasone—psoriasis	0.000199	0.00162	CcSEcCtD
Aminoglutethimide—Nausea—Cyclosporine—psoriasis	0.000197	0.0016	CcSEcCtD
Aminoglutethimide—Pruritus—Triamcinolone—psoriasis	0.000197	0.00159	CcSEcCtD
Aminoglutethimide—Dizziness—Hydrocortisone—psoriasis	0.000195	0.00158	CcSEcCtD
Aminoglutethimide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000194	0.015	CbGpPWpGaD
Aminoglutethimide—Nausea—Mycophenolate mofetil—psoriasis	0.000193	0.00156	CcSEcCtD
Aminoglutethimide—CYP1A2—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000192	0.0148	CbGpPWpGaD
Aminoglutethimide—Myalgia—Methotrexate—psoriasis	0.000192	0.00155	CcSEcCtD
Aminoglutethimide—Decreased appetite—Prednisone—psoriasis	0.000191	0.00155	CcSEcCtD
Aminoglutethimide—CYP19A1—Tryptophan metabolism—CAT—psoriasis	0.000191	0.0147	CbGpPWpGaD
Aminoglutethimide—Rash—Prednisolone—psoriasis	0.000191	0.00154	CcSEcCtD
Aminoglutethimide—Dermatitis—Prednisolone—psoriasis	0.000191	0.00154	CcSEcCtD
Aminoglutethimide—Headache—Prednisolone—psoriasis	0.000189	0.00153	CcSEcCtD
Aminoglutethimide—Vomiting—Hydrocortisone—psoriasis	0.000188	0.00152	CcSEcCtD
Aminoglutethimide—Rash—Hydrocortisone—psoriasis	0.000186	0.00151	CcSEcCtD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—ZMIZ1—psoriasis	0.000186	0.0144	CbGpPWpGaD
Aminoglutethimide—Dermatitis—Hydrocortisone—psoriasis	0.000186	0.00151	CcSEcCtD
Aminoglutethimide—Headache—Hydrocortisone—psoriasis	0.000185	0.0015	CcSEcCtD
Aminoglutethimide—Dizziness—Triamcinolone—psoriasis	0.000184	0.00149	CcSEcCtD
Aminoglutethimide—Nausea—Prednisolone—psoriasis	0.00018	0.00145	CcSEcCtD
Aminoglutethimide—Pruritus—Betamethasone—psoriasis	0.000179	0.00145	CcSEcCtD
Aminoglutethimide—Pruritus—Dexamethasone—psoriasis	0.000179	0.00145	CcSEcCtD
Aminoglutethimide—Vomiting—Triamcinolone—psoriasis	0.000177	0.00143	CcSEcCtD
Aminoglutethimide—Nausea—Hydrocortisone—psoriasis	0.000175	0.00142	CcSEcCtD
Aminoglutethimide—Rash—Triamcinolone—psoriasis	0.000175	0.00142	CcSEcCtD
Aminoglutethimide—Dermatitis—Triamcinolone—psoriasis	0.000175	0.00142	CcSEcCtD
Aminoglutethimide—Anorexia—Methotrexate—psoriasis	0.000175	0.00142	CcSEcCtD
Aminoglutethimide—Urticaria—Prednisone—psoriasis	0.000175	0.00141	CcSEcCtD
Aminoglutethimide—Headache—Triamcinolone—psoriasis	0.000174	0.00141	CcSEcCtD
Aminoglutethimide—Body temperature increased—Prednisone—psoriasis	0.000174	0.00141	CcSEcCtD
Aminoglutethimide—Hypotension—Methotrexate—psoriasis	0.000172	0.00139	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000167	0.00136	CcSEcCtD
Aminoglutethimide—Dizziness—Betamethasone—psoriasis	0.000167	0.00135	CcSEcCtD
Aminoglutethimide—Dizziness—Dexamethasone—psoriasis	0.000167	0.00135	CcSEcCtD
Aminoglutethimide—Nausea—Triamcinolone—psoriasis	0.000165	0.00134	CcSEcCtD
Aminoglutethimide—Somnolence—Methotrexate—psoriasis	0.000163	0.00132	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Prednisone—psoriasis	0.000162	0.00131	CcSEcCtD
Aminoglutethimide—Vomiting—Dexamethasone—psoriasis	0.00016	0.0013	CcSEcCtD
Aminoglutethimide—Vomiting—Betamethasone—psoriasis	0.00016	0.0013	CcSEcCtD
Aminoglutethimide—Decreased appetite—Methotrexate—psoriasis	0.00016	0.00129	CcSEcCtD
Aminoglutethimide—Rash—Betamethasone—psoriasis	0.000159	0.00129	CcSEcCtD
Aminoglutethimide—Rash—Dexamethasone—psoriasis	0.000159	0.00129	CcSEcCtD
Aminoglutethimide—Dermatitis—Dexamethasone—psoriasis	0.000159	0.00129	CcSEcCtD
Aminoglutethimide—Dermatitis—Betamethasone—psoriasis	0.000159	0.00129	CcSEcCtD
Aminoglutethimide—Headache—Dexamethasone—psoriasis	0.000158	0.00128	CcSEcCtD
Aminoglutethimide—Headache—Betamethasone—psoriasis	0.000158	0.00128	CcSEcCtD
Aminoglutethimide—CYP1A2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000157	0.0121	CbGpPWpGaD
Aminoglutethimide—Pruritus—Prednisone—psoriasis	0.000155	0.00126	CcSEcCtD
Aminoglutethimide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00015	0.0116	CbGpPWpGaD
Aminoglutethimide—Nausea—Dexamethasone—psoriasis	0.00015	0.00121	CcSEcCtD
Aminoglutethimide—Nausea—Betamethasone—psoriasis	0.00015	0.00121	CcSEcCtD
Aminoglutethimide—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000148	0.0114	CbGpPWpGaD
Aminoglutethimide—Urticaria—Methotrexate—psoriasis	0.000146	0.00118	CcSEcCtD
Aminoglutethimide—Dizziness—Prednisone—psoriasis	0.000145	0.00118	CcSEcCtD
Aminoglutethimide—Body temperature increased—Methotrexate—psoriasis	0.000145	0.00118	CcSEcCtD
Aminoglutethimide—Vomiting—Prednisone—psoriasis	0.00014	0.00113	CcSEcCtD
Aminoglutethimide—Rash—Prednisone—psoriasis	0.000139	0.00112	CcSEcCtD
Aminoglutethimide—Dermatitis—Prednisone—psoriasis	0.000138	0.00112	CcSEcCtD
Aminoglutethimide—Headache—Prednisone—psoriasis	0.000138	0.00112	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Methotrexate—psoriasis	0.000135	0.0011	CcSEcCtD
Aminoglutethimide—Nausea—Prednisone—psoriasis	0.000131	0.00106	CcSEcCtD
Aminoglutethimide—Pruritus—Methotrexate—psoriasis	0.00013	0.00105	CcSEcCtD
Aminoglutethimide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000122	0.00938	CbGpPWpGaD
Aminoglutethimide—Dizziness—Methotrexate—psoriasis	0.000121	0.000984	CcSEcCtD
Aminoglutethimide—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.00012	0.00925	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Corticotropin-releasing hormone—NFKBIA—psoriasis	0.00012	0.00924	CbGpPWpGaD
Aminoglutethimide—Vomiting—Methotrexate—psoriasis	0.000117	0.000946	CcSEcCtD
Aminoglutethimide—Rash—Methotrexate—psoriasis	0.000116	0.000938	CcSEcCtD
Aminoglutethimide—Dermatitis—Methotrexate—psoriasis	0.000116	0.000937	CcSEcCtD
Aminoglutethimide—Headache—Methotrexate—psoriasis	0.000115	0.000932	CcSEcCtD
Aminoglutethimide—Nausea—Methotrexate—psoriasis	0.000109	0.000884	CcSEcCtD
Aminoglutethimide—CYP2C19—Biological oxidations—CYP2S1—psoriasis	0.000107	0.00828	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	0.000106	0.00817	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.000104	0.00803	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	9.52e-05	0.00735	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	9.32e-05	0.00719	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	8.92e-05	0.00688	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Corticotropin-releasing hormone—CXCL8—psoriasis	8.54e-05	0.00659	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Biological oxidations—CYP2S1—psoriasis	8.36e-05	0.00645	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	8.25e-05	0.00636	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	8.24e-05	0.00635	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	8.11e-05	0.00626	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Corticotropin-releasing hormone—NFKB1—psoriasis	7.65e-05	0.0059	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Tryptophan metabolism—CAT—psoriasis	7.22e-05	0.00557	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	6.89e-05	0.00531	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—NDUFA5—psoriasis	6.72e-05	0.00518	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Biological oxidations—CYP2S1—psoriasis	6.46e-05	0.00498	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	6.37e-05	0.00491	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.26e-05	0.00483	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	6.22e-05	0.0048	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	6.19e-05	0.00478	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—CYP2S1—psoriasis	5.71e-05	0.00441	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Tryptophan metabolism—CAT—psoriasis	5.57e-05	0.0043	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	4.82e-05	0.00372	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	4.8e-05	0.0037	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—NDUFA5—psoriasis	4.45e-05	0.00343	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.15e-05	0.0032	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	4.01e-05	0.00309	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—CYP2S1—psoriasis	3.78e-05	0.00292	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—JUN—psoriasis	3.54e-05	0.00273	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	3.46e-05	0.00267	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—psoriasis	3.41e-05	0.00263	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	3.33e-05	0.00257	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—psoriasis	3.09e-05	0.00239	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	3.03e-05	0.00233	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.99e-05	0.00231	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—CARM1—psoriasis	2.79e-05	0.00215	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.61e-05	0.00201	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	2.59e-05	0.002	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	2.59e-05	0.002	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—TP53—psoriasis	2.34e-05	0.0018	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—NDUFA5—psoriasis	2.16e-05	0.00167	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.01e-05	0.00155	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.98e-05	0.00153	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—CARM1—psoriasis	1.85e-05	0.00143	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—CYP2S1—psoriasis	1.84e-05	0.00142	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.73e-05	0.00133	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—CAT—psoriasis	1.72e-05	0.00132	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—NDUFA5—psoriasis	1.68e-05	0.0013	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.57e-05	0.00121	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—CYP2S1—psoriasis	1.43e-05	0.0011	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—APOE—psoriasis	1.33e-05	0.00103	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—NDUFA5—psoriasis	1.3e-05	0.001	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—PPARG—psoriasis	1.16e-05	0.000896	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—CAT—psoriasis	1.14e-05	0.000877	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—CYP2S1—psoriasis	1.1e-05	0.000852	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.62e-06	0.000742	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—CARM1—psoriasis	8.97e-06	0.000692	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—APOE—psoriasis	8.83e-06	0.000681	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.38e-06	0.000647	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—PPARG—psoriasis	7.69e-06	0.000593	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.5e-06	0.000578	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—CARM1—psoriasis	6.99e-06	0.000539	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.53e-06	0.000504	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—CAT—psoriasis	5.51e-06	0.000425	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—CARM1—psoriasis	5.39e-06	0.000416	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—CAT—psoriasis	4.3e-06	0.000332	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—APOE—psoriasis	4.28e-06	0.000331	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—PPARG—psoriasis	3.73e-06	0.000288	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—APOE—psoriasis	3.34e-06	0.000258	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—CAT—psoriasis	3.32e-06	0.000256	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—PPARG—psoriasis	2.91e-06	0.000224	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—APOE—psoriasis	2.58e-06	0.000199	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—PPARG—psoriasis	2.24e-06	0.000173	CbGpPWpGaD
